Mod­er­na near­ing deal with US gov­ern­ment to de­vel­op Ebo­la vac­cines — re­port

The biggest pan­dem­ic biotech dar­ling is re­port­ed­ly one step clos­er to se­cur­ing a new deal for oth­er se­ri­ous in­fec­tious dis­eases.

Mod­er­na is near­ing an agree­ment with the US gov­ern­ment to de­vel­op vac­cines for Ebo­la and ad­di­tion­al virus­es con­sid­ered to be threats, Bloomberg re­port­ed Wednes­day. The deal is ex­pect­ed to see Mod­er­na work with re­searchers from the Uni­ver­si­ty of Texas Med­ical Branch at Galve­ston to em­u­late its rapid ap­proach to Covid-19 for such virus­es.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.